Prognostic factors in pathologic parametrium-positive patients with stage IB-IIB cervical cancer treated by radical surgery and adjuvant therapy

Gynecologic Oncology

Volumn 105, Issue 3, 2007, Pages 757-761

  Kodama, Junichi ^a   Seki, Noriko ^a   Nakamura, Keiichiro ^a   Hongo, Atsushi ^a   Hiramatsu, Yuji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Lymph node metastasis; Parametrial invasion; Prognosis; Vaginal invasion

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; SURGICAL TECHNIQUE; UTERINE CERVIX CANCER;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIC FLOOR; RADIOTHERAPY, ADJUVANT; UTERINE CERVICAL NEOPLASMS;

EID: 34248357290     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.02.019     Document Type: Article

References (17)

1. Hacker N.F. Cervical cancer. In: Berek J.S., and Hacker N.F. (Eds). Practical gynecologic oncology. 4th ed. (2005), Lippincott Williams and Wilkins 337-395
2. Peters III W.A., Liu P.Y., Barrett II R.J., Stock R.J., Monk B.J., Berek J.S., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clin. Oncol. 18 8 (2000) 1606-1613
3. Monk B.J., Wang J., Im S., Stock R.J., Peters III W.A., Liu P.Y., et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol. Oncol. 96 (2005) 721-728
4. Suprasert P., Srisomboon J., and Kasamatsu T. Radical hysterectomy for stage IIB cervical cancer: a review. Int. J. Gynecol. Oncol. 15 (2005) 995-1001
5. Estape R.E., Angioli R., Madrigal M., Janicek M., Gomez C., Penalver M., et al. Close vaginal margins as a prognostic factor after radical hysterectomy. Gynecol. Oncol. 68 (1998) 229-232
6. Ayhan A., Al R.A., Baykal C., Demirtas E., Yuce K., and Ayhan A. A comparison of prognoses of FIGO stage IB adenocarcinoma and squamous cell carcinoma. Int. J. Gynecol. Cancer 14 (2004) 279-285
7. Loh T.O., Wang P.H., Yen M.S., Chao K.C., Ng H.T., and Yuan C.C. Identifying local tumor variables for operable node-negative, margin-free patients with bulky cervical carcinoma of FIGO stage IB, IIA and IIB without adjuvant therapies. Eur. J. Gynaecol. Oncol. 22 6 (2001) 420-422
8. Piver M.S., and Chung W.S. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet. Gynecol. 46 (1975) 507-510
9. Uno T., Ito H., Itami J., Sato T., Minoura S., Yasuda S., et al. Adjuvant pelvic irradiation in patients with pathologic T2b carcinoma of the uterine cervix. In. J. Gynecol. Cancer 12 (2002) 187-191
10. Kodama J., Seki N., Ojima Y., Nakamura K., Hongo A., and Hiramatsu Y. Prognostic factors in node-positive patients with stage IB-IIB cervical cancer treated by radical hysterectomy and pelvic lymphadenectomy. Int. J. Gynecol. Obstet. 93 (2006) 130-135
11. Winter R., Haas J., Reich O., Koemetter R., Tamussino K., Lahousen M., et al. Parametrial spread of cervical cancer in patients with negative pelvic lymph nodes. Gynecol. Oncol. 84 (2002) 252-257
12. Kodaira T., Fuwa N., Nakanishi T., Kuzuya K., Sasaoka M., Furutani K., et al. Retrospective analysis of postoperative radiotherapy for node-negative cervical carcinoma with stage IB-IIB disease. Jpn. J. Clin. Oncol. 32 7 (2002) 255-261
13. Eifel P.J., Burke T.W., Morris M., and Smith T.L. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol. Oncol. 59 (1995) 38-44
14. Farley J.H., Hickey K.W., Carlson J.W., Rose E.R., Kost E.R., and Harrison T.A. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Cancer 97 (2003) 2196-2202
15. Landoni F., Maneo A., Colombo A., Placa F., Milani R., Perego P., et al. Randomized study of radical surgery versus radiotherapy for stage IB-IIa cervical cancer. Lancet 350 (1997) 535-540
16. Iwasaka T., Kamaru T., Yokoyama M., Matsuo N., Nakano H., and Sugimori H. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma: a comparison with effects of adjuvant radiotherapy. Obstet. gynecol. 91 (1998) 977-981
17. Takeshima N., Umayahara K., Fujiwara K., Hirai Y., Takizawa K., and Hasumi K. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer. Gynecol. Oncol. 103 (2006) 618-622